相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa
Xiuzhen Di et al.
JOURNAL OF ANTIBIOTICS (2015)
Polymyxin Combinations: Pharmacokinetics and Pharmacodynamics for Rationale Use
Phillip J. Bergen et al.
PHARMACOTHERAPY (2015)
Susceptibility of Multiresistant Gram-Negative Bacteria to Fosfomycin and Performance of Different Susceptibility Testing Methods
L. V. Perdigao-Neto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
Ilias Karaiskos et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
10 x '20 Progress-Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2013)
What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review
Suzanne Parker et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey
Tulin Demir et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)
In vitro Activity of Doripenem plus Fosfomycin against Drug-Resistant Clinical Blood Isolates
T. Lingscheid et al.
PHARMACOLOGY (2013)
Forgotten Antibiotics: An Inventory in Europe, the United States, Canada, and Australia
Celine Pulcini et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fosfomycin: an oldunew antibiotic
R. Raz
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
G. Samonis et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions
Gerard McCaughey et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods
Ching-Lan Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
Johan W. Mouton et al.
DRUG RESISTANCE UPDATES (2011)
Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now
Laura Freire-Moran et al.
DRUG RESISTANCE UPDATES (2011)
Will new antimicrobials overcome resistance among Gram-negatives?
Matteo Bassetti et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Adverse events associated with intravenous fosfomycin
Amelie Florent et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model
Juergen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Fosfomycin: an old, new friend?
M. Popovic et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials
George Samonis et al.
FUTURE MICROBIOLOGY (2010)
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Antibiotics and the Social History of the Controlled Clinical Trial, 1950-1970
Scott H. Podolsky
JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES (2010)
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2010)
Development and Qualification of a Pharmacodynamic Model for the Pronounced Inoculum Effect of Ceftazidime against Pseudomonas aeruginosa
Juergen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Susceptibility of Urinary Tract Bacteria to Fosfomycin
Sofia Maraki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies
Matthew E. Falagas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
Nikos Roussos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
David L. MacLeod et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Fosfomycin: Use beyond urinary tract and gastrointestinal infections
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections
James A. Driscoll et al.
DRUGS (2007)
Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections
Teresita Mazzei et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae
S Ribes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Short-course gentamicin in combination with Daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
BT Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems
S Mizunaga et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections
GA Pankey et al.
CLINICAL INFECTIOUS DISEASES (2004)
Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis
B Pfausler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Target site penetration of fosfomycin in critically ill patients
C Joukhadar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
In vitro activity of fosfomycin in combination with various antistaphylococcal substances
K Grif et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues
M Frossard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
